Global experience with PSMA-based alpha therapy in prostate cancer

PURPOSE: This review discusses the current state of prostate-specific membrane antigen (PSMA)-based alpha therapy of metastatic castration-resistant prostate cancer (mCRPC). With this in-depth discussion on the growing field of PSMA-based alpha therapy (PAT), we aimed to increase the interactions be...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathekge, Mike M., Bruchertseifer, Frank, Vorster, Mariza, Morgenstern, Alfred, Lawal, Ismaheel O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712297/
https://www.ncbi.nlm.nih.gov/pubmed/34173838
http://dx.doi.org/10.1007/s00259-021-05434-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712297/
https://www.ncbi.nlm.nih.gov/pubmed/34173838
http://dx.doi.org/10.1007/s00259-021-05434-9

Ejemplares similares